[en] BACKGROUND: There is considerable variability in COVID-19 outcomes amongst younger adults-and some of this variation may be due to genetic predisposition. We characterized the clinical implications of the major genetic risk factor for COVID-19 severity, and its age-dependent effect, using individual-level data in a large international multi-centre consortium. METHOD: The major common COVID-19 genetic risk factor is a chromosome 3 locus, tagged by the marker rs10490770. We combined individual level data for 13,424 COVID-19 positive patients (N=6,689 hospitalized) from 17 cohorts in nine countries to assess the association of this genetic marker with mortality, COVID-19-related complications and laboratory values. We next examined if the magnitude of these associations varied by age and were independent from known clinical COVID-19 risk factors. FINDINGS: We found that rs10490770 risk allele carriers experienced an increased risk of all-cause mortality (hazard ratio [HR] 1·4, 95% confidence interval [CI] 1·2-1·6) and COVID-19 related mortality (HR 1·5, 95%CI 1·3-1·8). Risk allele carriers had increased odds of several COVID-19 complications: severe respiratory failure (odds ratio [OR] 2·0, 95%CI 1·6-2·6), venous thromboembolism (OR 1·7, 95%CI 1·2-2·4), and hepatic injury (OR 1·6, 95%CI 1·2-2·0). Risk allele carriers ≤ 60 years had higher odds of death or severe respiratory failure (OR 2·6, 95%CI 1·8-3·9) compared to those > 60 years OR 1·5 (95%CI 1·3-1·9, interaction p-value=0·04). Amongst individuals ≤ 60 years who died or experienced severe respiratory COVID-19 outcome, we found that 31·8% (95%CI 27·6-36·2) were risk variant carriers, compared to 13·9% (95%CI 12·6-15·2%) of those not experiencing these outcomes. Prediction of death or severe respiratory failure among those ≤ 60 years improved when including the risk allele (AUC 0·82 vs 0·84, p=0·016) and the prediction ability of rs10490770 risk allele was similar to, or better than, most established clinical risk factors. INTERPRETATION: The major common COVID-19 risk locus on chromosome 3 is associated with increased risks of morbidity and mortality-and these are more pronounced amongst individuals ≤ 60 years. The effect on COVID-19 severity was similar to, or larger than most established risk factors, suggesting potential implications for clinical risk management. FUNDING: Funding was obtained by each of the participating cohorts individually.
Disciplines :
Immunology & infectious disease
Author, co-author :
Nakanishi, Tomoko
Pigazzini, Sara
Degenhardt, Frauke
Cordioli, Mattia
Butler-Laporte, Guillaume
Maya-Miles, Douglas
Nafría-Jiménez, Beatriz
Bouysran, Youssef
Niemi, Mari
Palom, Adriana
Ellinghaus, David
Khan, Atlas
Martínez-Bueno, Manuel
Rolker, Selina
Amitano, Sara
Tato, Luisa Roade
Fava, Francesca
Spinner, Christoph D.
Prati, Daniele
Bernardo, David
Garcia, Federico
DARCIS, Gilles ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses - médecine interne
Fernández-Cadenas, Israel
Holter, Jan Cato
Banales, Jesus
Frithiof, Robert
Kiryluk, Krzysztof
Duga, Stefano
Asselta, Rosanna
Pereira, Alexandre C.
Romero-Gómez, Manuel
Bujanda, Luis
Hov, Johannes R.
Migeotte, Isabelle
Renieri, Alessandra
Planas, Anna M.
Ludwig, Kerstin U.
Buti, Maria
Rahmouni, Souad ; Université de Liège - ULiège > GIGA Medical Genomics - Unit of Animal Genomics
Alarcón-Riquelme, Marta E.
Schulte, Eva C.
Franke, Andre
Karlsen, Tom H.
Valenti, Luca
Zeberg, Hugo
Richards, J. Brent
Ganna, Andrea
Georges, Michel ; Université de Liège - ULiège > Dpt. de gestion vétérinaire des Ressources Animales (DRA) > Génomique animale
Moutschen, Michel ; Université de Liège - ULiège > Département des sciences cliniques > Immunopath. - Maladies infect. et médec. interne gén.
Misset, Benoît ; Université de Liège - ULiège > Département des sciences cliniques > Soins intensifs
GUIOT, Julien ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de pneumologie - allergologie
Parzibut, Gilles ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service des soins intensifs
MEURIS, Christelle ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses - médecine interne
THYS, Marie ; Centre Hospitalier Universitaire de Liège - CHU > Département de gestion des systèmes d'informations (GSI) > Secteur exploitation des données
JACQUES, Jessica ; Centre Hospitalier Universitaire de Liège - CHU > Département de gestion des systèmes d'informations (GSI) > Secteur exploitation des données
LEONARD, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Clinique de médecine des voyageurs
FRIPPIAT, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses - médecine interne
GIOT, Jean-Baptiste ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses - médecine interne
SAUVAGE, Anne-Sophie ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses - médecine interne
VON FRENCKELL, Christian ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de rhumatologie
LAMBERMONT, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service des soins intensifs
MALAISE, Olivier ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de rhumatologie
BOVY, Christophe ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de néphrologie
BOUQUEGNEAU, Antoine ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de néphrologie
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
McKee M, Stuckler D. If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future. Nat Med. 2020;26(5):640-642.
Buitrago-Garcia D, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARSCoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020;17(9):e1003346.
Dooling K, et al. The Advisory Committee on immunization practices' updated interim recommendation for allocation of COVID-19 vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep. 2021;69(5152):1657-1660.
Bubar KM, et al. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science. 2021;371(6532):916-921.
Novelli G, et al. COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy. Hum Genomics. 2021;15(1):1-13.
O'Driscoll M, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2020;590(7844):140-145.
Williamson EJ, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430-436.
Chaudhry R, et al. A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes. EClinicalMedicine. 2020;25:100464.
Baric RS. Emergence of a highly fit SARS-CoV-2 variant. N Engl J Med. 2020;383(27):2684-2686.
Van Der Kolk DM, et al. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: High cancer incidence at older age. Breast Cancer Res Treat. 2010;124(3):643-651.
Nordestgaard BG, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. Eur Heart J. 2013;34(45):3478-3490.
Feng YCA, et al. Findings and insights from the genetic investigation of age of first reported occurrence for complex disorders in the UK Biobank and FinnGen [preprint]. https://doi.org/10.1101/2020.11.20.20234302. Posted on medRxiv November 25, 2020.
Olarte L, et al. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics. ArchNeurol. 2006;63(11):1586-1590.
The Severe Covid-19 GWAS Group. Genome wide association study of severe Covid-19 with respiratory failure. N Engl J Med. 2020;383:1522-1534.
Pairo-Castineira E, et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2020;591(7848):92-98.
COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19 [published online July 8, 2021]. Nature. https://doi.org/10.1038/s41586-021-03767-x.
Kosmicki JA, et al. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals. Am J Hum Genet. 2021;108(7):1350-1355.
Zeberg H, Pääbo S. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals. Nature. 2020;587(7835):610-612.
Karczewski KJ, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434-443.
Auton A, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68-74.
Del Valle DM, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;(3):1-8.
Merrill JT, et al. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020;16(10):581-589.
Higuera-de la Tijera F, et al. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19. Liver Res. 2021;5(1):21-27.
Vafadar Moradi E, et al. Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality. Am J Emerg Med. 2021;40:11-14.
Yan L, et al. An interpretable mortality prediction model for COVID-19 patients. Nat Mach Intell. 2020;2(5):283-288.
Polack FP, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603-2615.
Poustchi H, et al. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis. 2021;21(4):473-481.
Vuille-Dit-Bille RN, et al. Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. Amino Acids. 2015;47(4):693-705.
Yao Y, et al. Genome and epigenome editing identify CCR9 and SLC6A20 as target genes at the 3p21.31 locus associated with severe COVID-19. SignalTransductTargetTher. 2021;6(1):85.
Smieszek SP, Polymeropoulos MH. Role of FYVE and coiled-coil domain autophagy adaptor 1 in severity of COVID-19 1 infection 2 [preprint]. https://doi.org/10.1101/2021.01.22.21250070. Posted on medRxiv January 27, 2021.
Payne DJ, et al. The CXCR6/CXCL16 axis links inflamm-aging to disease severity in COVID-19 patients [preprint]. https://doi.org/10.1101/2021.01.25.428125. Posted on bioRxiv January 25, 2021.
Khalil BA, et al. Chemokines and chemokine receptors during COVID-19 infection. Comput Struct Biotechnol J. 2021;19:976-988.
Chua RL, et al. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020;38(8):970-979.
Liao M, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020;26(6):842-844.
Fry A, et al. Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026-1034.
Griffith GJ, et al. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020;11(1):1-12.
Miyara M, et al. Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19 [preprint]. https://doi.org/10.32388/WPP19W.3. Posted on Qeios April 21, 2020.
Di Maria E, et al. Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis. Hum Genomics. 2020;14(1):30.
Altshuler DM, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467(7311):52-58.
Marshall JC, et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192-e197.
Signorelli C, Odone A. Age-specific COVID-19 case-fatality rate: no evidence of changes over time. Int J Public Health. 2020;65(8):1435-1436.
Centers for Disease Control and Prevention. People With Certain Medical Conditions. https://www.cdc.gov/coronavirus/2019-ncov/needextra-precautions/people-with-medicalconditions.html. Updated August 20, 2021. Accessed January 29, 2021.
Purcell S, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575.
Downes DJ, et al. Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus. Nat Genet. 2021;53(11):1606-1615.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.